Company Filing History:
7 out of 2,488 
7 out of 1,157 Years Active: 2014-2022
Title: Innovations in Renal Therapy: The Contributions of John Kenneth Leypoldt
Introduction: John Kenneth Leypoldt, an accomplished inventor based in Libertyville, IL, has made significant contributions to the field of renal therapy. With a total of seven patents to his name, Leypoldt has focused his efforts on developing advanced technologies that enhance the treatment of renal failure.
Latest Patents: Among his latest innovations is the patent for "Therapy prediction and optimization for renal failure blood therapy." This system is designed to improve the efficiency of renal failure blood therapy machines. It incorporates concentration levels for multiple solutes removed from a patient's blood and features a display device that allows healthcare providers to select removed solutes easily. The device then estimates essential patient parameters and identifies a range of acceptable therapy treatments, enabling healthcare professionals to tailor the therapy accordingly. This innovation plays a crucial role in both conventional and home hemodialysis settings, providing valuable support for patients in need of renal therapy.
Career Highlights: John Kenneth Leypoldt has gathered extensive experience working with notable organizations in the healthcare sector. He has been associated with Baxter International Inc. and Baxter Healthcare SA, where he has contributed to advancements in medical technology. His work has led to significant improvements in patient care, especially for individuals suffering from renal conditions.
Collaborations: Throughout his career, Leypoldt has had the opportunity to collaborate with talented colleagues in the field. Noteworthy collaborators include Alp Akonur and Ying-Cheng Lo, who have been instrumental in driving innovation in renal therapy alongside Leypoldt.
Conclusion: John Kenneth Leypoldt's innovations continue to pave the way for improved therapies in renal failure treatment. With his seven patents and ongoing commitment to enhancing patient care, Leypoldt exemplifies the spirit of innovation that drives progress in the medical field. His contributions not only impact the technology used but also significantly enhance the quality of life for patients undergoing renal therapy.